DTP-poliovirus vaccine (Daiichi sankyo/Kitasato institute/Sanofi pasteur)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameDTP-poliovirus vaccine (Daiichi sankyo/Kitasato institute/Sanofi pasteur)
Drug Alias NameDTP-IPV - Kitasato/ Daiichi SankyoPetussis, diptheria, tetanus, inactivated-poliovirus Salk vaccine - Kitasato/ Daiichi SankyoDTP-poliovirus vaccine - Daiichi Sankyo Kitasato Institute/SanofiDTP-IPV vaccineIPV-DTP - Daiichi Sankyo +[10] 
ClassificationVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsPoliomyelitisTetanusDiphtheria +[4] 
Global Approved IndicationsPoliomyelitisTetanusDiphtheria +[4] 
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date2014/07/04
Country/TerritoryJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesKitasato Daiichi Sankyo VaccineSanofi Pasteur
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsPoliomyelitisTetanusDiphtheria +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeJ07CA02
Related LinksN/A